Retreatment With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma in ZUMA-5
Year: 2020
Type: conference-abstract
Source: Blood
Institutions: University of South Florida, Moffitt Cancer Center, Dana-Farber Cancer Institute, UPMC Hillman Cancer Center, The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, Hôpital Lyon Sud, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Kite (United States)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097262114